Breast cancer is the second most common cancer in Korean women and its incidence has increased. Among the various treatment methods for breast cancer, chemotherapy plays an important role. The use chemotherapy to treat breast cancer began at the mid 20th century and first combination chemotherapy was conducted in mid 1970s. This chemotherapy reduced breast cancer mortality up to 25~30%, anthracycline and taxane based chemotherapeutic regimens are widely used. Chemotherapy could be classified to neoadjuavnt, adjuvant and palliative setting according to its aim and role. In this review, various drug therapeutic options and their backgrounds are considered based on neoadjuvant, adjuvant and metastatic systemic therapies.

Citations

Citations to this article as recorded by  

• Developing of an Integrative Medicine Inpatient Care Program for Breast Cancer Patients Post-Chemotherapy
  Eun-Bin Ko, Jun-Bock Jang, Deok-Sang Hwang
  Perspectives on Integrative Medicine.2025; 4(1): 51.     CrossRef
• Effects of a Group Coaching Program on Depression, Anxiety and Hope in Women with Breast Cancer Undergoing Chemotherapy
  So Ryoung Seong, Moon-kyung Cho, Jeeyoon Kim, Yeo Ok Kim
  Asian Oncology Nursing.2017; 17(3): 188.     CrossRef
• The phenomenological study of self-management intervention among breast cancer survivors: Non-pharmacological approaches
  Seok-Mo Heo, Narae Heo
  Journal of the Korea Academia-Industrial cooperation Society.2016; 17(12): 270.     CrossRef